CARLYLE SECURED LENDING INC (CGBD) Fundamental Analysis & Valuation

NASDAQ:CGBD • US8722801029

Current stock price

10.83 USD
-0.14 (-1.28%)
At close:
10.83 USD
0 (0%)
After Hours:

This CGBD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CGBD Profitability Analysis

1.1 Basic Checks

  • In the past year CGBD was profitable.
  • CGBD had a negative operating cash flow in the past year.
  • Each year in the past 5 years CGBD has been profitable.
  • Of the past 5 years CGBD 4 years had a positive operating cash flow.
CGBD Yearly Net Income VS EBIT VS OCF VS FCFCGBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • CGBD's Return On Assets of 2.48% is in line compared to the rest of the industry. CGBD outperforms 50.21% of its industry peers.
  • CGBD has a Return On Equity of 5.92%. This is comparable to the rest of the industry: CGBD outperforms 45.19% of its industry peers.
  • CGBD has a Return On Invested Capital (2.95%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for CGBD is below the industry average of 7.23%.
Industry RankSector Rank
ROA 2.48%
ROE 5.92%
ROIC 2.95%
ROA(3y)3.83%
ROA(5y)4.65%
ROE(3y)8.36%
ROE(5y)10.12%
ROIC(3y)3.99%
ROIC(5y)3.91%
CGBD Yearly ROA, ROE, ROICCGBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With a decent Profit Margin value of 27.06%, CGBD is doing good in the industry, outperforming 70.71% of the companies in the same industry.
  • CGBD's Profit Margin has improved in the last couple of years.
  • CGBD's Operating Margin of 39.42% is fine compared to the rest of the industry. CGBD outperforms 70.29% of its industry peers.
  • In the last couple of years the Operating Margin of CGBD has declined.
  • With a Gross Margin value of 42.26%, CGBD perfoms like the industry average, outperforming 43.93% of the companies in the same industry.
  • CGBD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 39.42%
PM (TTM) 27.06%
GM 42.26%
OM growth 3Y-7.72%
OM growth 5Y-4.17%
PM growth 3Y-11.93%
PM growth 5Y60.68%
GM growth 3Y-7.31%
GM growth 5Y-3.57%
CGBD Yearly Profit, Operating, Gross MarginsCGBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

3

2. CGBD Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CGBD has been increased compared to 1 year ago.
  • The number of shares outstanding for CGBD has been increased compared to 5 years ago.
  • Compared to 1 year ago, CGBD has a worse debt to assets ratio.
CGBD Yearly Shares OutstandingCGBD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CGBD Yearly Total Debt VS Total AssetsCGBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • CGBD has an Altman-Z score of 0.49. This is a bad value and indicates that CGBD is not financially healthy and even has some risk of bankruptcy.
  • CGBD's Altman-Z score of 0.49 is in line compared to the rest of the industry. CGBD outperforms 40.17% of its industry peers.
  • CGBD has a Debt/Equity ratio of 1.31. This is a high value indicating a heavy dependency on external financing.
  • CGBD's Debt to Equity ratio of 1.31 is on the low side compared to the rest of the industry. CGBD is outperformed by 65.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF N/A
Altman-Z 0.49
ROIC/WACCN/A
WACCN/A
CGBD Yearly LT Debt VS Equity VS FCFCGBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • CGBD has a Current Ratio of 3.27. This indicates that CGBD is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 3.27, CGBD belongs to the best of the industry, outperforming 82.01% of the companies in the same industry.
  • CGBD has a Quick Ratio of 3.27. This indicates that CGBD is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 3.27, CGBD belongs to the best of the industry, outperforming 82.01% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 3.27
CGBD Yearly Current Assets VS Current LiabilitesCGBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2

3. CGBD Growth Analysis

3.1 Past

  • CGBD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.00%.
  • Measured over the past 5 years, CGBD shows a small growth in Earnings Per Share. The EPS has been growing by 0.53% on average per year.
  • CGBD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.88%.
  • Measured over the past years, CGBD shows a small growth in Revenue. The Revenue has been growing by 7.01% on average per year.
EPS 1Y (TTM)-23%
EPS 3Y-7.25%
EPS 5Y0.53%
EPS Q2Q%-23.4%
Revenue 1Y (TTM)9.88%
Revenue growth 3Y7.23%
Revenue growth 5Y7.01%
Sales Q2Q%18.74%

3.2 Future

  • Based on estimates for the next years, CGBD will show a very negative growth in Earnings Per Share. The EPS will decrease by -14.91% on average per year.
  • The Revenue is expected to decrease by -0.29% on average over the next years.
EPS Next Y-0.98%
EPS Next 2Y-0.45%
EPS Next 3Y-14.91%
EPS Next 5YN/A
Revenue Next Year0.94%
Revenue Next 2Y1.37%
Revenue Next 3Y-0.29%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CGBD Yearly Revenue VS EstimatesCGBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M 250M
CGBD Yearly EPS VS EstimatesCGBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

5

4. CGBD Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 7.03 indicates a rather cheap valuation of CGBD.
  • Based on the Price/Earnings ratio, CGBD is valued cheaper than 81.59% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, CGBD is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 7.10, the valuation of CGBD can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, CGBD is valued cheaper than 84.94% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.68, CGBD is valued rather cheaply.
Industry RankSector Rank
PE 7.03
Fwd PE 7.1
CGBD Price Earnings VS Forward Price EarningsCGBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGBD Per share dataCGBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • CGBD's earnings are expected to decrease with -14.91% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)13.33
EPS Next 2Y-0.45%
EPS Next 3Y-14.91%

5

5. CGBD Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 14.59%, CGBD is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 6.89, CGBD pays a better dividend. On top of this CGBD pays more dividend than 85.36% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CGBD pays a better dividend.
Industry RankSector Rank
Dividend Yield 14.59%

5.2 History

  • The dividend of CGBD decreases each year by -0.15%.
  • CGBD has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-0.15%
Div Incr Years0
Div Non Decr Years0
CGBD Yearly Dividends per shareCGBD Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • CGBD pays out 150.46% of its income as dividend. This is not a sustainable payout ratio.
  • CGBD's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP150.46%
EPS Next 2Y-0.45%
EPS Next 3Y-14.91%
CGBD Yearly Income VS Free CF VS DividendCGBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M
CGBD Dividend Payout.CGBD Dividend Payout, showing the Payout Ratio.CGBD Dividend Payout.PayoutRetained Earnings

CGBD Fundamentals: All Metrics, Ratios and Statistics

CARLYLE SECURED LENDING INC

NASDAQ:CGBD (4/9/2026, 8:17:31 PM)

After market: 10.83 0 (0%)

10.83

-0.14 (-1.28%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-24
Earnings (Next)05-04
Inst Owners39.82%
Inst Owner Change0%
Ins Owners0.39%
Ins Owner Change3.86%
Market Cap765.46M
Revenue(TTM)255.57M
Net Income(TTM)69.15M
Analysts72.86
Price Target13.52 (24.84%)
Short Float %4.09%
Short Ratio4.06
Dividend
Industry RankSector Rank
Dividend Yield 14.59%
Yearly Dividend1.7
Dividend Growth(5Y)-0.15%
DP150.46%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-31
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.78%
Min EPS beat(2)-5.88%
Max EPS beat(2)-5.68%
EPS beat(4)0
Avg EPS beat(4)-5.29%
Min EPS beat(4)-7.06%
Max EPS beat(4)-2.53%
EPS beat(8)2
Avg EPS beat(8)-2.32%
EPS beat(12)5
Avg EPS beat(12)-0.82%
EPS beat(16)9
Avg EPS beat(16)3.34%
Revenue beat(2)0
Avg Revenue beat(2)-4.92%
Min Revenue beat(2)-6.33%
Max Revenue beat(2)-3.52%
Revenue beat(4)0
Avg Revenue beat(4)-5.17%
Min Revenue beat(4)-7.79%
Max Revenue beat(4)-3.03%
Revenue beat(8)2
Avg Revenue beat(8)-3.42%
Revenue beat(12)3
Avg Revenue beat(12)-2.52%
Revenue beat(16)7
Avg Revenue beat(16)0.2%
PT rev (1m)-0.8%
PT rev (3m)-0.8%
EPS NQ rev (1m)-4.72%
EPS NQ rev (3m)-5.4%
EPS NY rev (1m)-0.99%
EPS NY rev (3m)-1.9%
Revenue NQ rev (1m)-2.83%
Revenue NQ rev (3m)-4.53%
Revenue NY rev (1m)-2.04%
Revenue NY rev (3m)-3.69%
Valuation
Industry RankSector Rank
PE 7.03
Fwd PE 7.1
P/S 3
P/FCF N/A
P/OCF N/A
P/B 0.66
P/tB 0.66
EV/EBITDA N/A
EPS(TTM)1.54
EY14.22%
EPS(NY)1.52
Fwd EY14.08%
FCF(TTM)-2.89
FCFYN/A
OCF(TTM)-2.89
OCFYN/A
SpS3.62
BVpS16.52
TBVpS16.52
PEG (NY)N/A
PEG (5Y)13.33
Graham Number23.92
Profitability
Industry RankSector Rank
ROA 2.48%
ROE 5.92%
ROCE 3.73%
ROIC 2.95%
ROICexc 3%
ROICexgc 3%
OM 39.42%
PM (TTM) 27.06%
GM 42.26%
FCFM N/A
ROA(3y)3.83%
ROA(5y)4.65%
ROE(3y)8.36%
ROE(5y)10.12%
ROIC(3y)3.99%
ROIC(5y)3.91%
ROICexc(3y)4.11%
ROICexc(5y)4.02%
ROICexgc(3y)4.11%
ROICexgc(5y)4.02%
ROCE(3y)5.05%
ROCE(5y)4.95%
ROICexgc growth 3Y-10.51%
ROICexgc growth 5Y-4.93%
ROICexc growth 3Y-10.51%
ROICexc growth 5Y-4.94%
OM growth 3Y-7.72%
OM growth 5Y-4.17%
PM growth 3Y-11.93%
PM growth 5Y60.68%
GM growth 3Y-7.31%
GM growth 5Y-3.57%
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.3
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.27
Quick Ratio 3.27
Altman-Z 0.49
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23%
EPS 3Y-7.25%
EPS 5Y0.53%
EPS Q2Q%-23.4%
EPS Next Y-0.98%
EPS Next 2Y-0.45%
EPS Next 3Y-14.91%
EPS Next 5YN/A
Revenue 1Y (TTM)9.88%
Revenue growth 3Y7.23%
Revenue growth 5Y7.01%
Sales Q2Q%18.74%
Revenue Next Year0.94%
Revenue Next 2Y1.37%
Revenue Next 3Y-0.29%
Revenue Next 5YN/A
EBIT growth 1Y-3.99%
EBIT growth 3Y-1.05%
EBIT growth 5Y2.56%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-296.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-296.19%
OCF growth 3YN/A
OCF growth 5YN/A

CARLYLE SECURED LENDING INC / CGBD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CARLYLE SECURED LENDING INC (CGBD) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CGBD.


What is the valuation status of CARLYLE SECURED LENDING INC (CGBD) stock?

ChartMill assigns a valuation rating of 5 / 10 to CARLYLE SECURED LENDING INC (CGBD). This can be considered as Fairly Valued.


How profitable is CARLYLE SECURED LENDING INC (CGBD) stock?

CARLYLE SECURED LENDING INC (CGBD) has a profitability rating of 4 / 10.


How financially healthy is CARLYLE SECURED LENDING INC?

The financial health rating of CARLYLE SECURED LENDING INC (CGBD) is 3 / 10.


What is the earnings growth outlook for CARLYLE SECURED LENDING INC?

The Earnings per Share (EPS) of CARLYLE SECURED LENDING INC (CGBD) is expected to decline by -0.98% in the next year.